[MNPR] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 11.18%
YoY- 18.58%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -1,715 -1,641 -1,814 -1,954 -2,200 -2,435 -2,896 -29.50%
Tax -1,789 -1,723 -2 112,146 128,087 -90 -14 2444.51%
NP -1,715 -1,641 -1,814 -1,954 -2,200 -2,344 -2,883 -29.29%
Tax Rate - - - - - - - -
Total Cost 1,715 1,641 1,814 1,954 2,200 2,344 2,883 -29.29%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.49 -0.10 -0.12 -0.14 -0.16 -0.18 -0.22 70.63%
EPS Diluted -0.49 -0.10 -0.12 -0.14 -0.16 -0.18 -0.22 70.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.